Serina Therapeutics (SER) Current Deferred Revenue (2017 - 2020)
Serina Therapeutics (SER) posted Current Deferred Revenue of $300,000 for Q4 2020, up 6.0% from $283,000 a year earlier and up 17.6% from the prior quarter.
Powered by 
Analysis
Serina Therapeutics (SER) Current Deferred Revenue (2017 - 2020) Analysis & Trends
Since Q4 2017, Serina Therapeutics has reported Current Deferred Revenue for 9 quarters.
- Annual Current Deferred Revenue shows a three-year compound annual growth rate of 18.6% (FY2017 to FY2020).
- In prior years, Serina Therapeutics' Current Deferred Revenue was $283,000 in FY2019 (-10.7%), $317,000 in FY2018 (+76.1%) and $180,000 in FY2017.
- Quarterly Current Deferred Revenue has run from a low of $180,000 in Q4 2017 to a high of $407,000 in Q1 2020 over five years.
- On a year-over-year basis, Current Deferred Revenue has increased in each of the last three quarters, with growth averaging 8.8% over the last four quarters.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $255,000 (Q3 2020), $328,000 (Q2 2020) and $407,000 (Q1 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Serina Therapeutics | 32.93 Mn | -7.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 300,000.00 |
| Sep 30, 2020 | 255,000.00 |
| Jun 30, 2020 | 328,000.00 |
| Mar 31, 2020 | 407,000.00 |
| Dec 31, 2019 | 283,000.00 |
| Sep 30, 2019 | 219,000.00 |
| Jun 30, 2019 | 266,000.00 |
| Dec 31, 2018 | 317,000.00 |
| Dec 31, 2017 | 180,000.00 |
API Access
Serina Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "SER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();